An audit of the use of antifungal agents

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 1, 1996, Pages 175-185

  Gutiérrez, Félix ^a   Wall, Patrick G ^b   Cohen, Jonathan ^c  

^a Marina Baixa Hospital   (Spain)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICONAZOLE;

ARTICLE; DRUG COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL LITERATURE; MYCOSIS; PRESCRIPTION; UNITED KINGDOM; UNIVERSITY HOSPITAL; PROSPECTIVE STUDY;

ANTIFUNGAL AGENTS; HUMANS; MEDICAL AUDIT; MYCOSES; PROSPECTIVE STUDIES;

EID: 0029691120     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.1.175     Document Type: Article

References (21)

1. Albert, M. M., Graybill, J. R. & Rinaldi, M. G. (1991). Treatment of murine cryptoccocal meningitis with an SCH 39304-amphotericin B combination. Antimicrobial Agents and Chemotherapy 35, 1721-25.
2. Anaissie, E. (1992). Opportunistic mycoses in the immunocompromised host: experience at a cancer centre and review. Clinical Infectious Diseases 14, Suppl. 1, S43-53.
3. Bennett, J. E. (1990). Antifungal Agents. In Principles and Practice of Infectious Diseases, 3rd edn (Mandell, G. L., Douglas, R. G. & Bennet, J. E., Eds), pp. 361-70. Churchill Livingstone, New York.
4. Carr, M. & Dismukes, W. E. (1992). Antifungal Drugs. In Infectious Diseases (Gorbach, S. L., Bartlett, J. G. & Blacklow, N. R., Eds), pp. 306-13. Saunders, Philadelphia.
5. Case, C. P., MacGowan, A. P., Brown, N. M., Reeves, D. S., Whitehead, P. & Felmingham, D. (1991). Prophylactic oral fluconazole and Candida fungaemia. Lancet 337, 790.
6. Como, J. A. & Dismukes, W. E. (1994). Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine 330, 263-72.
7. EORTC International Antimicrobial Therapy Cooperative Group (1989). Empiric antifungal therapy in febrile granulocytopenic patients. American Journal of Medicine 86, 668-72.
8. Gallis, H. A., Drew, R. H. & Pickard, W. W. (1990). Amphotericin B: 30 years of experience. Reviews of Infectious Diseases 12, 308-29.
9. Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandraseker, P. H., Fox, B., Kaizer, H. et al. (1992). A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine 326, 845-51.
10. Gross, M. H., Pichard, W. W. & Perfect, J. R. (1987). Retrospective review of amphotericin B use in a tertiary-care medical centre. American Journal of Hospital Pharmacy 44, 1353-7.
11. Lopez-Berestein, G., Bodey, G. P., Fainstem, V., Keating, M., Frankel, L. S., Zeluff, B. et al. (1989). Treatment of systemic fungal infections with liposomal amphotericin B. Archives of Internal Medicine 149, 2533-6.
12. Marr, J. J., Moffet, H. L. & Kunin, C. M. (1988). Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. Journal of Infectious Diseases 157, 869-76.
13. Medical Letter (1992). Drugs for treatment of fungal infections. Medical Letter on Drugs and Therapeutics 34, 14-16.
14. Meunier, F., Prentice, H. G. & Ringden, O. (1991), Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. Journal of Antimicrobial Chemotherapy 28, Suppl. B, 83-91.
15. Persons, D. A., Laughlin, M., Tanner, D., Perfect, J., Gockerman, J. P. & Hathorn, J. W. (1991). Fluconazole and Candida krusei fungaemia. New England Journal of Medicine 325, 1315.
16. Pizzo, P. A., Robichaud, K. J., Gill, F. A. & Witebsky, F. G. (1982). Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. American Journal of Medicine 72, 101-11.
17. Schaffner, A. & Frick, P. G. (1985). The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. Journal of Infectious Diseases 151, 902-10.
18. Terrell, C. L. & Hughes, C. E. (1992). Antifungal agents used for deep-seated mycotic infections. Mayo Clinic Proceedings 67, 69-91.
19. Walsh, T. J., Lee, J., Lecciones, J., Rubin, M , Butler, K., Francis, P. et al. (1991). Empiric therapy with amphotericin B in febrile granulocytopenic patients. Reviews of Infectious Diseases 13, 496-503.
20. Warnock, D. W., Burke, J., Cope, N. J., Johnson, E. M., von Fraunhofer, N. A. & Williams, E. W. (1988). Fluconazole resistance in Candida glabrata. Lancet ii, 1310.
21. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. & Saral, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 325, 1274-7.